Copyright: ©Author(s) 2026.
World J Diabetes. Jul 15, 2026; 17(7): 119741
Published online Jul 15, 2026. doi: 10.4239/wjd.119741
Published online Jul 15, 2026. doi: 10.4239/wjd.119741
Figure 5 PF/polyhexamethylene biguanide-nicotinamide mononucleotide hydrogel upregulates the expression of vascular endothelial growth factor and transforming growth factor-β1.
A and B: Detection of VEGF and TGF-β1 mRNA expression in diabetic mouse wound tissues treated with different dressings by quantitative real-time-polymerase chain reaction; C: Western-blot analysis of vascular endothelial growth factor and transforming growth factor-β1 protein levels in diabetic mouse wound tissues treated with different dressings, with β-actin as the internal reference; D and E: Represent the quantification of protein expression levels. NMN: Nicotinamide mononucleotide; PHMB: Polyhexamethylene biguanide; TGF-β1: Transforming growth factor-β1; VEGF: Vascular endothelial growth factor.
- Citation: Peng F, Li YY, Tang Y, Sun SX, Zhu YQ, Zhang XY, Zhu HZ. Nicotinamide mononucleotide-loaded thermosensitive hydrogel promotes diabetic wound healing via antibacterial and antioxidant synergy in a mouse model. World J Diabetes 2026; 17(7): 119741
- URL: https://www.wjgnet.com/1948-9358/full/v17/i7/119741.htm
- DOI: https://dx.doi.org/10.4239/wjd.119741